Minmet (MNT) Quote

The he/she/it/they is an idiot, review it’s history….

DBMM news:

https://www.otcmarkets.com/stock/DBMM/news/story?e&id=2836111

~~COMPX 5/8/2024~~~~~~~

Previous Close

16,332.56 -16.69

16280 BullNBear52
16199 SSKILLZ1

News:

https://www.otcmarkets.com/stock/DBMM/news/story?e&id=2836111

All supports in place (N,S,E,W) and first level of sound boards in place. If the crew keeps up the pace, could energize the site as soon as this weekend.

https://investorshub.advfn.com/uimage/uploads/2024/5/8/jceursound_board.jpg

Let's make a bet 😁
If the Q1 2024 results disappoint and the closing price is negative, I will stop posting starting from Friday May 10, 2024.
But if the closing price tomorrow is positive, you will stop posting starting from Friday May 10, 2024.

Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc

I held 516 puts overnight and 520 calls, the calls will be down to a nickel or less at the bell I’m sure, but I can never out guess this market and some days the volatility can make money on both calls and puts

JB Rant if you missed -> https://www.optionmillionaires.com/jb-pre-market-rant-may-8th-2024/

Good morning A$ & LD

Chinese do still have a language communications problem. Its not as much as talking or writing English as it is in understanding what is means at times. Their language is pictorial of different symbols that when followed by a different symbol means a completely different picture in they mind. For th

$HHSE Filings & General Update

Greetings HHSE Friends - here is a quick summary of key items as of Friday, April 26, 2024:

1). OTC FILINGS - A second round of formatting and disclosure revisions were posted last night for the year-end report (12-31-2023); once this fili

Read the board and you will see...🥳

Sorry Theorysuit, I meant FeMike not you.

Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers May 08 2024 - 7:00AM

Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the de

$28 by the end of week

Good morning .0001ers

Bavi’s success doesn’t surprise me one bit. Problem is OncXerna is in no position to pay phase 3 royalties. Thus the slow walk of Bavi in all these phase 2 trials. Eliminate phase 3 royalties and allow Bavi to proceed to potential approval without the added financial burden for a yet unproven ent

Bro you think hedge funds and market makers read Ihub to figure out what to short or what to buy!!??

OMG

ROTFLMAO

GM "RNVA"

Yeah.......and who on planet earth would ever agree that a 20 YEAR PATENT TO TRADE STOCKS WITH BLOCKCHAIN isn't an asset.......
B E G I
2 0 2 4
B U L L I S H ! ! ! ! ! ! !

It might have turned sour..........

NIVF....................................https://stockcharts.com/h-sc/ui?s=NIVF&p=W&yr=1&mn=3&dy=0&id=p96837884856

CSPI bottom line looks good. But what's going on with the top line?? Revenues down over 10% sequentially, and pretty flat vs last year (when there was no AZT). Lowest revenue in several quarters. So that's not great. Stock could still trade higher, but I think the disappointing revenue keeps a